Study Design
This multicenter, double-blind, placebo-controlled randomized clinical trial was conducted at 3 medical centers in eastern China. Ethical approval was obtained from the ethics committees of all study centers. This study was registered on the Chinese Clinical Trial Registry before enrolling the first patient. All patients provided written informed consent. The study adhered to the principles outlined in the Declaration of Helsinki